Joint Venture and Cooperation Agreement between ShareholdersJoint Venture and Cooperation Agreement • October 16th, 2008 • China Biologic Products, Inc. • Biological products, (no disgnostic substances)
Whereas, Party A entered into a Joint Venture and Cooperation Agreement between Shareholders with FAN Qingchun ("Transferor") on November 8, 2005 for purpose of joint acquisition of 68% equity interest held by Jiao Da Rui Shen in Huitian Blood Products Co., Ltd. ("Huitian"). After the acquisition, Party A held 65% of the equity interests in Huitian, while the Transferor held 35% of the equity interests in Huitian. After registration of the equity transfer with the administration for industry and commerce, both Parties have been jointly operating Huitian till now. In July 2008, the Transferor proposed to transfer 35% of the equity interests it held in Huitian due to its own reasons and recommended Party B as the Transferee.
Equity Transfer AgreementEquity Transfer Agreement • October 16th, 2008 • China Biologic Products, Inc. • Biological products, (no disgnostic substances)
The Transferor is an individual residing in the People's Republic of China with the ID card No. 412901196912053094 and his address is Room 508, Building 2, Suojinsicun, Xuanwu District, Nanjing City.
Agreement on Equity Transfer, Acquisition, Joint Venture and CooperationEquity Transfer Agreement • October 16th, 2008 • China Biologic Products, Inc. • Biological products, (no disgnostic substances)
Whereas, Party B has proposed to transfer 35% of equity interest it holds in Huitain Blood Products Co., Ltd. ("Huitian"), and after Party A's consent, Party A and Party B entered into the Agreement for Termination of the Joint Venture and Cooperation Agreement between Shareholders, according to which Party A agreed to Party C purchasing the 35% of equity interest Party B holds in Huitian and to Party B and Party C entering into equity transfer agreement (this Agreement shall prevail in case of any discrepancy). According to the relevant provisions by the agreement among the Parties, the Parties have agreed as follows in regards to the relevant issues:
AgreementInvestment Agreement • October 16th, 2008 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • Shandong
The above three Parties agree that Party A entrusts Party C for investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"). According to the principles of good faith, equality and mutual benefits, equivalence and voluntariness, after full consultation the three Parties agree as follows in regards to relevant issues:
